UNSPSC 51421507: Timobesone acetate

This classification denotes a therapeutic glucocorticoid with the molecular formula C24H31FO5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LGO8R495QW, chemically known as s-methyl 9-fluoro-11beta,17-dihydroxy-16beta-methyl-3-oxoandrosta-1,4-diene-17beta-carbothioate, 17-acetate but more generally known as timobesone acetate, which bears US NIH Compound Identifier 3033679. Most nations, for tariff and trade purposes, schedule timobesone acetate under HS 29372200 and SITC 54153.

As of Q4 2014, TIMOBESONE ACETATE remains US FDA's Preferred Term for this commodity. Timobesone acetate bears US NLM identifiers UMLS ID C0637015 and NCI Concept Code C90957. SMILES: C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)SC)OC(=O)C)C)O)F)C.

UNSPSC 51421507 Timobesone acetate is a Commodity code with no meaningful recent state and local procurement activity. The two opportunities tagged under this code—Seminole County's solicitation for Naloxone and Safe Drug Deactivation Systems (IFB), and the Texas Health and Human Services Commission's Request for Information on Direct-to-Manufacturer Prescriptions (RFI)—fall outside the scope of timobesone acetate, a glucocorticosteroid pharmaceutical. Neither opportunity involves procurement of timobesone acetate specifically or any steroid products. The code appears to be a miscategorization or data-entry error in the state and local procurement records available.

This code shows no relevant recent activity and merits a skip unless your intelligence suggests that state and local health agencies plan timobesone acetate procurement under a different code designation or that the opportunities above will be retagged with the correct pharmaceutical classifications.